Suppr超能文献

老年患者焦虑症的最佳管理

Optimal management of anxiety in older patients.

作者信息

Weiss K J

机构信息

Delaware Valley Research Associates Inc., King of Prussia, Pennsylvania, USA.

出版信息

Drugs Aging. 1996 Sep;9(3):191-201. doi: 10.2165/00002512-199609030-00005.

Abstract

Although the incidence of anxiety disorders diminishes with age, the prevalence of anxiety symptoms among older patients is substantial. These symptoms, which include cognitive and somatic manifestations, are a source of diminished quality of life. The many potential sources of illness- and medication-induced anxiety must be excluded before instituting treatment. The general principles of antianxiety medication treatment in older patients include: (i) symptom relief with minimum sedation; (ii) improvement in sleep; (iii) freedom from autonomic and cognitive toxicities; and (iv) freedom from physical dependence and drug interactions. Older compounds such as the tricyclic antidepressants should be avoided, since more modern agents (e.g. benzodiazepines and buspirone) are well tolerated and effective. Modern antidepressants have also been used to reduce anxiety symptoms, although there is a potential for the opposite effect to occur. The selective serotonin reuptake inhibitors appear to be better suited to treating syndromes such as panic and obsessive-compulsive disorder, whereas nefazodone would be a better choice for generalised anxiety complicated by depression.

摘要

尽管焦虑症的发病率会随着年龄增长而降低,但老年患者中焦虑症状的患病率却相当高。这些症状包括认知和躯体表现,是生活质量下降的一个原因。在开始治疗之前,必须排除许多由疾病和药物引起焦虑的潜在因素。老年患者抗焦虑药物治疗的一般原则包括:(i)以最小的镇静作用缓解症状;(ii)改善睡眠;(iii)无自主神经和认知毒性;(iv)无身体依赖性和药物相互作用。应避免使用如三环类抗抑郁药等较老的化合物,因为更现代的药物(如苯二氮䓬类药物和丁螺环酮)耐受性良好且有效。现代抗抑郁药也已被用于减轻焦虑症状,尽管可能会出现相反的效果。选择性5-羟色胺再摄取抑制剂似乎更适合治疗恐慌和强迫症等综合征,而奈法唑酮对于伴有抑郁症的广泛性焦虑症是更好的选择。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验